News Focus
News Focus
Replies to #70314 on Biotech Values
icon url

rkrw

12/18/08 7:22 AM

#70321 RE: DewDiligence #70314

Barer was the CEO ages ago, then turned it over to John Jackson. Jackson retired and Barer took it back. Celgene has definitely been an amazing stock, one of the few bios that's exceeded their 1999-2000 highs.